Fenwal Inc recalls Amicus MNC Apheresis Kit - Double Needle - Product Usage: intended for use in the collection of blood components and mo…
- Recall date
- February 25, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1343-2021
- FDA classification
- Class II
- Brand / firm
- Fenwal Inc
- Sold / distributed
- US Nationwide distribution in the states of GA, TX, TN, MD, CA, KS, MN, MA, NM, NC, LA, CO, KY, NV, PA, UT, MI, NJ, IL, MD, OH, NY, FL.
Why it was recalled
Some lots of Amicus MNC Apheresis and Amicus Exchange kits have leaking centrifuge packs during a procedure on the Amicus Separator using therapeutic protocols only. The defect is a blood leak at the boot, elbow, or in the channel on the separation chamber of the centrifuge pack.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Amicus MNC Apheresis Kit - Double Needle - Product Usage: intended for use in the collection of blood components and mononuclear cells.
Get recall alerts
Free email alert whenever Fenwal Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fenwal Inc